Abiopharma

🔍 Schugel Jason E. (Executive)

Company: WEBSTER FINANCIAL CORP (WBS)

Report Date: 2026-08-13

Detailed Transactions and Holdings:

• Sold 830 shares of Common Stock at $79.07 per share (Direct)
  Date: 2026-08-13 | Code: F | equity_swap_involved: 0 | shares_owned_after: 19,834.19 | transaction_form_type: 4 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-13 | Code: H | shares_owned_after: 20,664.19 | Footnotes: F1

Footnotes:

• F1: Reflects 470.192 shares purchased through Webster Financial Corporation's Employee Stock Purchase Plan, as amended and restated effective April 1, 2019, since most recent Form 4 filed on March 13, 2026.
• F2: Represents the tax withholding upon the vesting of certain time-based restricted shares that were accelerated pursuant to the Transaction Agreement, dated as of February 3, 2026, by and among Webster Financial Corporation, Banco Santander, S.A. and Webster Virginia Corporation.